Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants.
Allaw F, Haddad SF, Zakhour J, Kanj SS.
Int J Antimicrob Agents. 2023 Aug;62(2):106860. doi: 10.1016/j.ijantimicag.2023.106860. Epub 2023 May 21.
PMID:37220849
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update.
Wang Y, Chang YJ, Chen J, Han M, Hu J, Hu J, Huang H, Lai Y, Liu D, Liu Q, Luo Y, Jiang EL, Jiang M, Song Y, Tang XW, Wu D, Xia LH, Xu K, Zhang X, Zhang XH, Huang X.
Cancer Lett. 2024 Nov 28;605:217264. doi: 10.1016/j.canlet.2024.217264. Epub 2024 Sep 25.
PMID:39332587
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions.